This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) slid 0.33% to $613.05 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.65% to 3,935.18 and Dow Jones Industrial Average falling 1.02% to 31,834.11. Regeneron Pharmaceuticals Inc. closed $134.37 short of its 52-week high ($747.42), which the company achieved on April 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 0.54% to $176.13, Novartis AG ADR (NOVN.EB) fell 0.41% to $84.04, and Amgen Inc. (AMGN) fell 0.03% to $240.64. Trading volume (703,974) eclipsed its 50-day average volume of 660,944.
Data source: Dow Jones Market Data, FactSet. Data compiled May 11, 2022.
(END) Dow Jones Newswires
May 11, 2022 17:18 ET (21:18 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.